News

Creating more value.
For doctors and patients

Information from science and research

Stay up to date!

Majority stake in HumanOptics AG to be sold to Chinese investor

Ad-hoc-Mitteilung gemäß Art. 17 MAR

Erlangen, August 30, 2019 - The Management Board of HumanOptics AG ("Company"), a leading technology company for the production of implants for eye surgery, was informed by its current majority shareholder Medipart AG, Unterägeri/Switzerland, ("Medipart") that Medipart signed a share purchase agreement to sell its stake of 73.4% in the share capital of the Company to a Chinese investor today. The closing of the sale is subject to the fulfillment to customary closing conditions, including approvals by Chinese public authorities.

End of the Ad-hoc-Disclosure

Contact:
HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Telefon: +49 (0) 9131 50665-0
E-Mail: IR@humanoptics.com

Ad-hoc-Disclosure, 30.08.2019

Archive

HumanOptics international

Wichtige Messetermine

OUR

CUSTOMER SERVICE

YOUR

QUESTIONS

Our experts support you with your questions at any time.

    *Mandatory field

    Resilient presbyopia correction: HumanOptics launches TRIVA

    News
    News

    The TRIVA is HumanOptics’ response to the new demands on vision caused by rapidly advancing digitalization. The trifocal posterior chamber IOL for presbyopia correction promises excellent visual results with three focal points, not only in the near and far range, but also especially at intermediate distances. The TRIVA is thus optimized for the use of […]